Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging randomized, clinical trial.

E Suhler, Lyndell Lim, Robert Beardsley, Tracy Giles, Sirichai Pasadhika, Shelly Lee, Alexandre de Saint Sardos, Nicholas Butler, Justine Smith, James Rosenbaum

    Research output: Contribution to journalArticlepeer-review

    66 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging randomized, clinical trial.'. Together they form a unique fingerprint.

    Medicine & Life Sciences